An Fe3O4/PEDOT:PSS nanocomposite as an advanced electroconductive material for the biosensing of the prostate-specific antigen in unprocessed human plasma samples
An Fe3O4/PEDOT:PSS nanocomposite as an advanced electroconductive material for the biosensing of the prostate-specific antigen in unprocessed human plasma samples
نویسندگان: مینا شبان , محمد حسن زاده محله , الهام صلحی
کلمات کلیدی: conductive polymer, prostate cancer, magnetic nanoparticles, immunosensor, glycoprotein.
نشریه: 0 , 44 , 11 , 2019
| نویسنده ثبت کننده مقاله |
محمد حسن زاده محله |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات آنالیز دارویی |
| کد مقاله |
69814 |
| عنوان فارسی مقاله |
An Fe3O4/PEDOT:PSS nanocomposite as an advanced electroconductive material for the biosensing of the prostate-specific antigen in unprocessed human plasma samples |
| عنوان لاتین مقاله |
An Fe3O4/PEDOT:PSS nanocomposite as an advanced electroconductive material for the biosensing of the prostate-specific antigen in unprocessed human plasma samples |
| ناشر |
3 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
Analytical Methods |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| A novel sandwich-type biosensor based on a signal amplification strategy of various nanocomposites was developed to monitor the prostate-specific antigen (PSA) in real samples. The engineered immunosensor was fabricated using iron oxide magnetic nanoparticles modified with a polymer poly(3,4-ethylenedioxythiophene):poly(styrene sulfonate) [Fe3O4/PEDOT:PSS] conductive nanocomposite that utilized the immobilization of primary antibodies (biotinylated antibody (Ab1)). In order to improve the electron transfer rate, a cysteamine-capped gold nanoparticle (AuNPs-CysA) was applied for conjugation with a secondary antibody (HRP-Ab2). The fabrication procedure was investigated by square wave voltammetry. Under optimized experimental conditions, the calibration curve showed a wide linear range (0.001–0.5 μg L−1) for the PSA biomarker with a low limit of quantification of 0.001 μg L−1. Finally, satisfactory results were obtained for the determination of PSA in untreated human plasma samples, indicating the potential of the immunoassay for applications in clinical bioanalysis. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| authorreprints.pdf | 1398/08/23 | 2058057 | دانلود |